National Academies Press: OpenBook
« Previous: References
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18549.
×

Appendix A

Workshop Agenda

Improving the Efficiency and Effectiveness of Genomic Science Translation: A Workshop

December 3, 2012

The Beckman Center of the National Academies
100 Academy
Irvine, CA

Workshop Objectives:

•   To examine how basic science can best be positioned to foster successful translation of early genomic discoveries.

•   To explore the challenges in and identify potential opportunities for improving the efficacy of the translation process.

•   To define pathways for moving innovative basic science forward.

 
8:30–8:45 A.M. WELCOMING REMARKS AND CHARGE TO WORKSHOP SPEAKERS AND PARTICIPANTS
 
 

Wylie Burke, Roundtable Co-Chair

Professor and Chair,

Department of Bioethics and Humanities

University of Washington, Seattle

 
 

Sharon Terry, Roundtable Co-Chair

President and Chief Executive Officer

Genetic Alliance

 
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18549.
×
8:45–10:20 A.M. SESSION I: CONNECTING BASIC RESEARCH AND HEALTH CARE NEEDS

Discussion Provocateur:
 

William J. Rutter

Chairman/Chief Executive Officer and Founder

Synergenics, LLC

 
8:45–9:05 A.M. Genomics to Health
 

Edison Liu

President and Chief Executive Officer

The Jackson Laboratory

 
9:05–9:25 A.M. Genomics and Personalized Cancer Treatment
 

David G. Huntsman

Associate Professor of Medicine

University of British Columbia

 
9:25–10:15 A.M. Discussion with Speakers and Attendees
 
10:15–10:20 A.M. Session Distillation and Potential Next Steps
 

William J. Rutter

Chairman/Chief Executive Officer and Founder

Synergenics, LLC

 
10:20–10:35 A.M. BREAK
 
10:35 A.M.–12:10 PM SESSION II: MOVING BASIC SCIENCE FORWARD
 
  Discussion Provocateur:
 

Robert L. Nussbaum

Chief, Division of Medical Genetics

Department of Medicine and Institute of Human Genetics

University of California, San Francisco

 
10:35–10:55 A.M. Discovering New Drugs and Diagnostics from 300 Billion Points of Data
 

Atul Butte

Chief and Associate Professor of Systems Medicine,

Department of Pediatrics

Stanford University School of Medicine

 
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18549.
×
10:55–11:15 A.M. Translating Genetic and Genomic Research in Neuropsychiatric Conditions: Lessons from Autism Research
 

Daniel Geschwind

Gordon and Virginia MacDonald Distinguished Chair in Human Genetics and Professor of Neurology and Psychiatry,

University of California, Los Angeles, School of Medicine

 
11:15 A.M.–12:05 P.M. Discussion with Speakers and Attendees
 
12:05–12:10 P.M. Session Distillation and Potential Next Steps
 

Robert L. Nussbaum

Chief, Division of Medical Genetics

Department of Medicine and Institute of Human Genetics

University of California, San Francisco, School of Medicine

 
12:10–1:00 P.M. WORKING LUNCH
 
1:00–2:35 P.M. SESSION III: THE ROLE OF INDUSTRY AND VENTURE CAPITAL

Discussion Provocateur:
 

Wylie Burke, Roundtable Co-Chair

Professor and Chair

Department of Bioethics and Humanities

University of Washington, Seattle

 
1:00–1:20 P.M. Lost in Translation: The Systematic and Comprehensive
 

Geoffrey Duyk

Partner and Managing Director

TPG Biotech

 
1:20–1:40 P.M. Translating Genomic Science into Clinical Practice: Time for Innovative Business Models
 

Randy Scott

Chairman and Chief Executive Officer

InVitae

 
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18549.
×
1:40–2:30 P.M. Discussion with Speakers and Attendees
 
2:30–2:35 P.M. Session Distillation and Potential Next Steps
 

Wylie Burke, Roundtable Co-Chair

Professor and Chair

Department of Bioethics and Humanities

University of Washington, Seattle

 
2:35–4:10 P.M. SESSION IV: THE ROLE OF ADVOCACY IN FACILITATING BASIC SCIENTIFIC RESEARCH

Discussion Provocateur:
 

Sharon Terry, Roundtable Co-Chair

President and Chief Executive Officer

Genetic Alliance

 
2:35–2:55 P.M. Purpose of Advocacy—Helping to Solve Important Problems
 

Pat Furlong

Founding President and Chief Executive Officer

Parent Project Muscular Dystrophy

 
2:55–3:15 P.M. Bridging the Gap Between Basic and Clinical Research
 

Todd Sherer

Chief Executive Officer

The Michael J. Fox Foundation for Parkinson’s Research

 
3:15–4:05 P.M. Discussion with Speakers and Attendees
 
4:05–4:10 P.M. Session Distillation and Potential Next Steps
 

Sharon Terry, Roundtable Co-Chair

President and Chief Executive Officer

Genetic Alliance

 
4:10–4:25 P.M. BREAK
 
4:25–5:30 P.M. SESSION V: NEXT STEPS
 
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18549.
×
4:25–5:30 P.M. LEADING THE STRATEGY FOR MORE EFFICIENT AND EFFECTIVE TRANSLATION

Discussion Provocateur:
 

Geoffrey Ginsburg

Director, Center for Genomic Medicine

Institute for Genomic Sciences & Policy

Duke University

 
  Discussants:

William J. Rutter

Chairman/Chief Executive Officer and Founder

Synergenics, LLC

 
 

Daniel Geschwind

Gordon and Virginia MacDonald Distinguished Chair in Human Genetics and Professor of Neurology and Psychiatry,

University of California, Los Angeles, School of Medicine

 
 

Geoffrey Duyk

Partner and Managing Director,

TPG Biotech

 
 

Todd Sherer

Chief Executive Officer,

The Michael J. Fox Foundation for Parkinson’s Research

 
5:30–5:45 P.M. SESSION VI: CONCLUSION
 
5:30–5:45 P.M. CONCLUDING REMARKS
 
 

Wylie Burke, Roundtable Co-Chair

Professor and Chair

Department of Bioethics and Humanities

University of Washington, Seattle

 
 

Sharon Terry, Roundtable Co-Chair

President and Chief Executive Officer

Genetic Alliance

 
5:45 P.M. ADJOURN
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18549.
×

This page intentionally left blank.

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18549.
×
Page 47
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18549.
×
Page 48
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18549.
×
Page 49
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18549.
×
Page 50
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18549.
×
Page 51
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18549.
×
Page 52
Next: Appendix B: Speaker Biographical Sketches »
Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary Get This Book
×
Buy Paperback | $37.00 Buy Ebook | $29.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The process for translating basic science discoveries into clinical applications has historically involved a linear and lengthy progression from initial discovery to preclinical testing, regulatory evaluation and approval, and, finally, use in clinical practice. The low rate of translation from basic science to clinical application has been a source of frustration for many scientists, clinicians, investors, policy makers, and patients who hoped that investments in research would result in improved products and processes for patients. Some feel that the anticipated deliverables from the Human Genome Project have not yet materialized, and although understanding of human health and disease biology has increased, there has not been a concomitant increase in the number of approved drugs for patients over the past 10 years.

Improving the Efficiency and Effectiveness of Genomic Science Translation is the summary of a workshop convened by the Institute of Medicine Roundtable on Translating Genomic-Based Research for Health in December 2012 to explore ways to improve the efficiency and effectiveness of the translation of genomic science to clinical practice. The workshop convened academic researchers, industry representatives, policy makers, and patient advocates to explore obstacles to the translation of research findings to clinical practice and to identify opportunities to support improvement of the early stages of the process for translation of genetic discoveries. This report discusses the realignment of academic incentives, the detection of innovative ways to fund translational research, and the generation or identification of alternative models that accurately reflect human biology or disease to provide opportunities to work across sectors to advance the translation of genomic discoveries.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!